Development Pipeline

 DiscoveryPreclinicalPhase 1Phase 2Phase 3
 Discovery Preclinical Phase 1 Phase 2 Phase 3
ACH-3102NS5A Inhibitor    
ACH-3422Nucleotide NS5B Polymerase Inhibitor   
SovaprevirNS3/4A Protease Inhibitor    
ACH-CFDIsComplement Factor D Inhibitors 

About Achillion

Headquartered in New Haven, CT,Achillion applies expertise in biology and structure-guided design and a deep understanding of patient and clinician needs to develop innovative treatment solutions aimed at improving the lives of patients. More...

HCV Education

About the Hepatitis C Virus

Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Click to learn more about this disease.

No upcoming events at this time.

You are now leaving this website. If you would like to continue, click Continue.